DM-Pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DM-Pharma
Largest movements
- Receivables within one year -€22,786
down €22,786 (-39.0%), from €58,448 to €35,661
of which Trade receivables: -€26,120
- Tangible fixed assets -€7,777
down €7,777 (-4.3%), from €179,663 to €171,886
- Cash +€7,101
up €7,101 (+423%), from €1,678 to €8,779
mainly Receivables within one year (+€22,786) and Other debts (+€15,762)
- Profit (loss) carried forward -€26,992
down €26,992 (-100%), from €26,992 to €0
- Other debts +€15,762
up €15,762 (+102%), from €15,440 to €31,202
- Debts after one year -€5,577
down €5,577 (-4.7%), from €118,336 to €112,759
- Tax, wage and social debts -€4,557
down €4,557 (-27.2%), from €16,733 to €12,175
- Short-term financial debts -€3,635
down €3,635 (-100%), from €3,635 to €0
- Gross operating margin -€35,893
down €35,893 (-68.1%), from €52,731 to €16,838
- Taxes -€6,050
down €6,050 (-76.4%), from €7,921 to €1,872
- Financial charges -€3,476
down €3,476 (-43.0%), from €8,080 to €4,605
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €240,882 | €217,870 | -€23,012 | -9.6% |
| Fixed assets | 21/28 | €179,663 | €171,886 | -€7,777 | -4.3% |
| Tangible fixed assets | 22/27 | €179,663 | €171,886 | -€7,777 | -4.3% |
| Land and buildings | 22 | €179,663 | €171,886 | -€7,777 | -4.3% |
| Current assets | 29/58 | €61,219 | €45,984 | -€15,235 | -24.9% |
| Amounts receivable within one year | 40/41 | €58,448 | €35,661 | -€22,786 | -39.0% |
| Trade receivables | 40 | €55,778 | €29,658 | -€26,120 | -46.8% |
| Other amounts receivable | 41 | €2,670 | €6,003 | +€3,334 | +125% |
| Cash at bank and in hand | 54/58 | €1,678 | €8,779 | +€7,101 | +423% |
| Deferred charges and accrued income | 490/1 | €1,094 | €1,544 | +€450 | +41.1% |
| Total equity and liabilities | 10/49 | €240,882 | €217,870 | -€23,012 | -9.6% |
| Equity | 10/15 | €76,534 | €49,542 | -€26,992 | -35.3% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €46,542 | €46,542 | = | 0.0% |
| Distributable reserves | 133 | €46,542 | €46,542 | = | 0.0% |
| Profit (loss) carried forward | 14 | €26,992 | €0 | -€26,992 | -100% |
| Amounts payable | 17/49 | €164,348 | €168,328 | +€3,980 | +2.4% |
| Amounts payable after more than one year | 17 | €118,336 | €112,759 | -€5,577 | -4.7% |
| Financial debts | 170/4 | €118,336 | €112,759 | -€5,577 | -4.7% |
| Amounts payable within one year | 42/48 | €44,963 | €55,569 | +€10,606 | +23.6% |
| Current portion of amounts payable after more than one year | 42 | €5,868 | €6,035 | +€167 | +2.8% |
| Financial debts | 43 | €3,635 | €0 | -€3,635 | -100% |
| Credit institutions | 430/8 | €3,635 | €0 | -€3,635 | -100% |
| Trade debts | 44 | €3,287 | €6,157 | +€2,870 | +87.3% |
| Suppliers | 440/4 | €3,287 | €6,157 | +€2,870 | +87.3% |
| Taxes, remuneration and social security | 45 | €16,733 | €12,175 | -€4,557 | -27.2% |
| Taxes | 450/3 | €16,733 | €12,175 | -€4,557 | -27.2% |
| Other amounts payable | 47/48 | €15,440 | €31,202 | +€15,762 | +102% |
| Accrued charges and deferred income | 492/3 | €1,049 | €0 | -€1,049 | -100% |
| Remuneration, social security and pensions | 62 | €0 | - | = | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,647 | €7,777 | +€130 | +1.7% |
| Other operating charges | 640/8 | €1,481 | €1,745 | +€264 | +17.8% |
| Gross operating margin | 9900 | €52,731 | €16,838 | -€35,893 | -68.1% |
| Operating profit (loss) | 9901 | €43,604 | €7,316 | -€36,287 | -83.2% |
| Financial income | 75/76B | - | €11 | +€11 | |
| Recurring financial income | 75 | - | €11 | +€11 | |
| Financial charges | 65/66B | €8,080 | €4,605 | -€3,476 | -43.0% |
| Recurring financial charges | 65 | €8,080 | €4,605 | -€3,476 | -43.0% |
| Profit (loss) for the period before taxes | 9903 | €35,523 | €2,723 | -€32,801 | -92.3% |
| Income taxes | 67/77 | €7,921 | €1,872 | -€6,050 | -76.4% |
| Profit (loss) for the period | 9904 | €27,602 | €851 | -€26,751 | -96.9% |
| Profit (loss) for the period to be appropriated | 9905 | €27,602 | €851 | -€26,751 | -96.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.